A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.

A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.

A chewable tablet formulation includes an active material comprising an active agent in a maltodextrin base and an inactive material comprising a sugar, rice bran, carnauba wax, maltodextrin and a flavoring agent.

A chewable tablet formulation includes an active material comprising an active agent in a maltodextrin base and an inactive material comprising a sugar, rice bran, carnauba wax, maltodextrin and a flavoring agent.

The present invention relates to a composition for improving anti-diabetic and anti-obesity effects, including an extract extracted from any one selected from the group consisting of Lonicera japonica (Lonicerae Flos), Scutellaria baicalensis (Scutellariae Radix), and Houttuynia cordata (Houttuyniae Herba). According to the present invention, it was confirmed that co-administration of the extract of the present invention and metformin, a representative anti-diabetic drug, increases an anti-diabetic effect and reduces side effects caused by metformin, and at the same time, exhibits an anti-obesity effect by suppressing fat accumulation. Therefore, the composition of the present invention is expected to be effective in treatment of diabetes mellitus.

The present invention relates to a composition for improving anti-diabetic and anti-obesity effects, including an extract extracted from any one selected from the group consisting of Lonicera japonica (Lonicerae Flos), Scutellaria baicalensis (Scutellariae Radix), and Houttuynia cordata (Houttuyniae Herba). According to the present invention, it was confirmed that co-administration of the extract of the present invention and metformin, a representative anti-diabetic drug, increases an anti-diabetic effect and reduces side effects caused by metformin, and at the same time, exhibits an anti-obesity effect by suppressing fat accumulation. Therefore, the composition of the present invention is expected to be effective in treatment of diabetes mellitus.

A system, accompanying apparatuses and methods relating to an oral, nasal or propellant enhanced mist delivery, drug delivery and lung cleansing apparatuses and having for an object to provide a safe and harmless means for and method of delivering medication with heated, moist, flavored air; or by inhaling warm medication like methanol into the lungs in case of a respiratory ailment under direction of a physician. Additionally, all state of the art medicines are envisioned for delivery with the system.

A valerian composition includes a therapeutically effective pharmaceutical dosage form having a solid core including a polymer in which valerian and a valerian stability improving amount of an acidifying agent are contained. The valerian stability improving amount of acidifying agent being sufficient to impart a pH of 2 to 5 to the polymer.

A valerian composition includes a therapeutically effective pharmaceutical dosage form having a solid core including a polymer in which valerian and a valerian stability improving amount of an acidifying agent are contained. The valerian stability improving amount of acidifying agent being sufficient to impart a pH of 2 to 5 to the polymer.

A composition can include a cannabinoid and caprylic acid triglyceride.